These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 31736860)

  • 1. Effects of CBD-Enriched
    Fleury-Teixeira P; Caixeta FV; Ramires da Silva LC; Brasil-Neto JP; Malcher-Lopes R
    Front Neurol; 2019; 10():1145. PubMed ID: 31736860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature.
    Bilge S; Ekici B
    J Cannabis Res; 2021 Dec; 3(1):53. PubMed ID: 34911567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits.
    Montagner PSS; Medeiros W; da Silva LCR; Borges CN; Brasil-Neto J; de Deus Silva Barbosa V; Caixeta FV; Malcher-Lopes R
    Front Psychiatry; 2023; 14():1210155. PubMed ID: 37671290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabidiol in Treatment of Autism Spectrum Disorder: A Case Study.
    Ma L; Platnick S; Platnick H
    Cureus; 2022 Aug; 14(8):e28442. PubMed ID: 36176817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol is a behavioral modulator in BTBR mouse model of idiopathic autism.
    Shrader SH; Mellen N; Cai J; Barnes GN; Song ZH
    Front Neurosci; 2024; 18():1359810. PubMed ID: 38784096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Family Implications of Cannabidiol (CBD)-Dominant Full-Spectrum Phytocannabinoid Extract in Children and Adolescents with Moderate to Severe Non-Syndromic Autism Spectrum Disorder (ASD): An Observational Study on Neurobehavioral Management.
    Mazza JAS; Ferreira LS; Martins-Vieira AF; Beserra DDL; Rodrigues VA; Malcher-Lopes R; Caixeta FV
    Pharmaceuticals (Basel); 2024 May; 17(6):. PubMed ID: 38931353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol as a suggested candidate for treatment of autism spectrum disorder.
    Poleg S; Golubchik P; Offen D; Weizman A
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():90-96. PubMed ID: 30171992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid treatment for the symptoms of autism spectrum disorder.
    Aran A; Cayam Rand D
    Expert Opin Emerg Drugs; 2024 Mar; 29(1):65-79. PubMed ID: 38226593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic role of Cannabidiol in mental health: a systematic review.
    Khan R; Naveed S; Mian N; Fida A; Raafey MA; Aedma KK
    J Cannabis Res; 2020 Jan; 2(1):2. PubMed ID: 33526132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind, and placebo-controlled clinical trial.
    Silva EAD; Medeiros WMB; Santos JPMD; Sousa JMM; Costa FBD; Pontes KM; Borges TC; Espínola C; Andrade E Silva AH; Nunes ELG; Alves NT; Rosa MDD; Albuquerque KLGD
    Trends Psychiatry Psychother; 2024; 46():e20210396. PubMed ID: 35617670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA; Zhou R; Jacobson C; Weng J; Cheng E; Lay J; Hung P; Lerner JT; Sankar R
    Epilepsy Behav; 2015 Jun; 47():138-41. PubMed ID: 25935511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review.
    de Camargo RW; de Novais Júnior LR; da Silva LM; Meneguzzo V; Daros GC; da Silva MG; de Bitencourt RM
    Pharmacol Biochem Behav; 2022 Nov; 221():173492. PubMed ID: 36379443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
    Pedrazzi JFC; Ferreira FR; Silva-Amaral D; Lima DA; Hallak JEC; Zuardi AW; Del-Bel EA; Guimarães FS; Costa KCM; Campos AC; Crippa ACS; Crippa JAS
    Psychopharmacology (Berl); 2022 Sep; 239(9):2713-2734. PubMed ID: 35904579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience.
    Tzadok M; Uliel-Siboni S; Linder I; Kramer U; Epstein O; Menascu S; Nissenkorn A; Yosef OB; Hyman E; Granot D; Dor M; Lerman-Sagie T; Ben-Zeev B
    Seizure; 2016 Feb; 35():41-4. PubMed ID: 26800377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
    Perry MS
    Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study.
    Hacohen M; Stolar OE; Berkovitch M; Elkana O; Kohn E; Hazan A; Heyman E; Sobol Y; Waissengreen D; Gal E; Dinstein I
    Transl Psychiatry; 2022 Sep; 12(1):375. PubMed ID: 36085294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
    Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autism and associated disorders: cannabis as a potential therapy.
    Babayeva M; Assefa H; Basu P; Loewy Z
    Front Biosci (Elite Ed); 2022 Jan; 14(1):1. PubMed ID: 35320905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies.
    Fusar-Poli L; Cavone V; Tinacci S; Concas I; Petralia A; Signorelli MS; Díaz-Caneja CM; Aguglia E
    Brain Sci; 2020 Aug; 10(9):. PubMed ID: 32825313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.